News: Home Page Research

Next Page »« Previous Page

VICC researchers in national spotlight

Wednesday, June 25th, 2014

by Dagny Stuart Early research suggests patients with advanced melanoma — the most deadly form of skin cancer — may benefit from both immunotherapies and targeted therapies aimed at specific gene mutations. However, no combinations of these two classes of drugs have been shown to be safe, so far. The results of the first such […]

HPV-Positive Head and Neck Cancer Patients May be Safely Treated with Lower Radiation Dose

Thursday, June 19th, 2014

by Dagny Stuart A new study suggests that lowering the dose of radiation therapy for some head and neck cancer patients may improve outcomes and cause fewer long-term side effects. The research was presented by lead author Anthony Cmelak, M.D., professor of Radiation Oncology at Vanderbilt-Ingram Cancer Center (VICC), during the 50th annual meeting of […]

Rising Tobacco Epidemic in Asia

Tuesday, June 10th, 2014

A new study estimates that tobacco smoking has been linked to approximately 2 million deaths among adult men and women in Asia in recent years and predicts a rising death toll. The study, published in PLOS Medicine, was led by Wei Zheng, M.D., Ph.D., MPH, professor of Medicine and director of the Vanderbilt Epidemiology Center, […]

Arteaga Assumes AACR Post

Tuesday, April 22nd, 2014

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center, has assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015. He was inaugurated during the AACR Annual Meeting which was held April 5-9, in San Diego. AACR, founded […]

NIH Grant Supports Colon Research

Friday, August 16th, 2013

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer. Most RNA works inside cells to translate genes into proteins that are necessary for organisms to function. Now, recent […]

Lovly earns Damon Runyon Cancer Research Award

Wednesday, July 17th, 2013

Christine Lovly, M.D., Ph.D., instructor in Medicine at the Vanderbilt University School of Medicine, has earned the 2013 Damon Runyon Clinical Investigator Award, which supports young physician-scientists conducting patient-oriented cancer research. The three-year award will provide $450,000 for Lovly’s research efforts in lung cancer. “I am so honored to receive this prestigious and competitive award […]

Penson leads prostate research

Friday, July 12th, 2013

David Penson, M.D., MPH, professor of Urologic Surgery, has received a $2 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study localized prostate cancer, the second leading cause of death among American men. “The goal is to find out what works best, in which patients, and in whose hands,” said Penson, the […]

Correa Earns GI Research Award

Monday, June 24th, 2013

The American Gastroenterological Association (AGA) has honored Pelayo Correa, M.D., with its Distinguished Achievement Award, which recognizes an individual for contributions to research that have advanced the science and practice of gastroenterology. Correa is Anne Potter Wilson Professor of Medicine in the Division of Gastroenterology, Hepatology and Nutrition and professor of Pathology, Microbiology and Immunology. […]

Regional variations in benign lung disease

Thursday, May 30th, 2013

By Dagny Stuart A study led by Vanderbilt University Medical Center investigators found that rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer. The results could have an impact on clinical guidelines and health policy for lung cancer screening. The study was presented by Stephen A. Deppen, M.A., M.S., […]

Arteaga Leads New Cancer Initiatives

Friday, May 10th, 2013

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology, has been appointed to a leadership role of two newly created cancer research initiatives at Vanderbilt-Ingram Cancer Center. He has been named the founding director of the Center for Cancer Targeted Therapies (CCTT) and director of the Vanderbilt-Ingram Cancer Center Research Network (VICCRN). The CCTT […]